Afficher la notice abrégée

dc.contributor.authorTulum, Öner
dc.contributor.authorAndreoni, Antonio
dc.contributor.authorLazonick, William
dc.date.accessioned2024-08-19T16:14:23Z
dc.date.available2024-08-19T16:14:23Z
dc.date.issued2022
dc.identifierONIX_20240819_9781009278140_103
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/142969
dc.description.abstractThis Element analyses the tension between innovation and financialisation in the UK pharmaceutical industry, focusing on AstraZeneca and GlaxoSmithKline. This title is also available as Open Access on Cambridge Core.
dc.languageEnglish
dc.relation.ispartofseriesElements in Reinventing Capitalism
dc.subject.classificationthema EDItEUR::K Economics, Finance, Business and Management::KC Economics
dc.subject.classificationthema EDItEUR::K Economics, Finance, Business and Management::KJ Business and Management::KJM Management and management techniques
dc.subject.classificationthema EDItEUR::K Economics, Finance, Business and Management::KJ Business and Management::KJC Business strategy
dc.subject.classificationthema EDItEUR::K Economics, Finance, Business and Management::KJ Business and Management::KJD Business innovation
dc.subject.classificationthema EDItEUR::K Economics, Finance, Business and Management::KN Industry and industrial studies::KND Manufacturing industries
dc.subject.othercorporate governance
dc.subject.othertaxation
dc.titleFrom Financialisation to Innovation in UK Big Pharma
dc.title.alternativeAstraZeneca and GlaxoSmithKline
dc.typebook
oapen.identifier.doi10.1017/9781009278140
oapen.relation.isPublishedBy12615a55-20f1-4eb5-a6c9-5eb6541f63e5
oapen.relation.isbn9781009278140
oapen.relation.isbn9781009278164
oapen.imprintSocial Sciences
oapen.series.numberRECA


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by-nc/4.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by-nc/4.0/